Effect of integrated Chinese and Western medicine for treatment of helicobacter pylori affection
-
摘要:
目的探讨中西医结合在治疗幽门螺杆菌感染的临床疗效。 方法将80例幽门螺杆菌感染患者按照抛硬币 方法随机分为两组，标记为治疗组、对照组，每组40例。对照组患者采用西医疗法，治疗组患者采用中西医联合治疗，比较两组患者临床治疗效果。 结果治疗组患者经过治疗后幽门螺杆菌根除率为95.0%，对照组患者经过治疗后幽门螺杆菌根除率为70.0%，两组患者间差异具有统计学意义（P ＜0.05）。治疗组患者恶心、食欲下降等并发症发生率为20.0%，对照组患者恶心、食欲下降等并发症发生率为52.5%，两组患者间差异具有统计学意义（P ＜0.05）。结论中西医结合治疗幽门螺杆菌感染可明显提高临床治疗效果，提高幽门螺杆菌根除率，明显降低不良反应的发生，值得临床进一步推广应用。 Abstract:Objective To explore the effect of Integrated Chinese and Western medicine for treatment of Helicobacter Pylori affection. Methods Eighty Helicobacter Pylori(HP) affected patients were randomly divided into 2 groups by tossing a coin, and were labeled with therapy group and control group, with 40 patients in each group. Western medicine was used in the control group, and Integrated Chinese and Western medicine was used in the therapy group. The clinical effect was compared between two groups. Results Eradication rate of HP in the therapy group was 95.0% after therapy,and the control group was 70.0%, respectively, with a significant difference(P ＜0.05). The commodity rate such as nausea, lower appetite in therapy group was 20.0%, which was 52.5% in the control group, the difference between two groups was significant(P ＜0.05). Conclusion Integrated Chinese and Western medicine for HP treatment can elevate clinical treatment effect, improve the eradication rate of HP,and lower the adverse effect, and deserve popularizing in clinical works. -
表 1 两组患者治疗的不良反应发生情况(n=40)
组别 恶心 食欲下降 腹部不适 皮疹 治疗组 5.02±3.21 2.17±2.15 1.26±0.18 0.12±1.26 对照组 8.24±4.33 7.23±3.26 4.36±1.28 2.13±1.26 χ2 l.26 2.31 3.21 2.16 P ＜0.05 ＜0.05 ＜0.05 ＜0.05 
下载: 导出CSV
-
[1] 姚希贤. 姚冬奇.中西医结合对幽门螺杆菌感染治疗价值的研究[J]. 医学与哲学, 2012, 33(10): 14-6. [2] 刘鹏程, 林上助, 王建中, 等. 中西药结合治疗幽门螺杆菌感染并功能性消化不良[J]. 中国基层医药, 2012, 19(18): 2787-8. [3] 林根友, 肖兆群, 陆维宏. 中西医结合补救治疗幽门螺杆菌感染的临床研究[J]. 中国现代医生, 2013, 51(18): 93-6. [4] 张万岱, 姚永莉. 幽门螺杆菌感染的中西医结合治疗进展[C]//第二十二届全国中西医结合消化系统疾病学术会谈沦文集, 2010: 20-4. [5] Stammberger HR, Kennedy DW, Anatomic Terminology Group. Paranasal sinuses: anatomic terminology and nomenclature[J]. Ann Otol Rhinol Laryngol Suppl, 1995, 167(6): 7-16. [6] Wormald PJ. The agger nasi cell: the key to understanding the anatomy of the frontal recess[J]. Otolaryngol Head Neck Surg, 2003, 129(5): 497-507. [7] Choi BI, Lee HJ, Han JK, et al. Detection of hypervascular nodular hepatocellular carcinomas: value of triphasic helical CT compared with iodized-oil CT[J]. AJR Am J Roentgenol, 1997, 168(1): 219-24. [8] Khan MA, Combs CS, Brunt EM, et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma [J]. Ann Nucl Med, 2000, 32(5): 792-7. [9] Tabit CE, Chung WB, Hamburg NM, et al. Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications[J]. Rev Endocr Metab Disord, 2010, 11(1, SI): 61-74. [10] Endemann DH, Schiffrin EL. Endothelial dysfunction[J]. J Am Soc Nephrol, 2010, 15(8): 1983-92. -
点击查看大图
表(1)
计量
- 文章访问数: 493
- HTML全文浏览量: 197
- PDF下载量: 2
- 被引次数: 0
